Overcoming Barriers In Cell-Based Cancer Therapy

Universal, off‑the‑shelf CAR‑T cell therapies using gene‑edited donor T cells are beginning to overcome key barriers of cost, delay and access in cell‑based cancer treatment.

Valueinvestor on Freepik